VR Adviser

VR Adviser as of Sept. 30, 2025

Portfolio Holdings for VR Adviser

VR Adviser holds 33 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Apogee Therapeutics (APGE) 19.0 $337M 8.5M 39.73
Mestera (MTSR) 11.0 $196M 3.8M 52.33
Ocular Therapeutix (OCUL) 8.7 $154M 13M 11.69
Cidara Therapeutics Com New (CDTX) 5.1 $91M 947k 95.76
Miragen Therapeutics (VRDN) 4.7 $84M 3.9M 21.58
Kalvista Pharmaceuticals (KALV) 4.6 $82M 6.7M 12.18
Oruka Therapeutics (ORKA) 4.5 $80M 4.1M 19.23
Oric Pharmaceuticals (ORIC) 4.5 $79M 6.6M 12.00
Enliven Therapeutics (ELVN) 3.7 $66M 3.2M 20.47
Cogent Biosciences (COGT) 3.2 $57M 4.0M 14.36
Cytomx Therapeutics (CTMX) 2.8 $50M 16M 3.19
Abivax Sa Sponsored Ads (ABVX) 2.8 $49M 577k 84.90
Savara (SVRA) 2.5 $45M 13M 3.57
Spyre Therapeutics Com New (SYRE) 2.5 $45M 2.7M 16.76
Erasca (ERAS) 2.2 $39M 18M 2.18
Dianthus Therapeutics (DNTH) 2.1 $38M 961k 39.35
Engene Holdings (ENGN) 1.9 $35M 5.0M 6.83
Maze Therapeatics (MAZE) 1.8 $32M 1.2M 25.93
Jade Biosciences Com New (JBIO) 1.6 $28M 3.2M 8.63
Dyne Therapeutics (DYN) 1.5 $28M 2.2M 12.65
Vor Biopharma Com New 1.4 $24M 500k 48.72
Upstream Bio (UPB) 1.2 $22M 1.2M 18.81
Zura Bio Class A Ord Shs (ZURA) 1.1 $20M 4.6M 4.33
Astria Therapeutics (ATXS) 1.0 $18M 2.5M 7.28
Pharvaris N V (PHVS) 0.9 $17M 675k 24.95
Crescent Biopharma (CBIO) 0.9 $17M 1.4M 11.89
Septerna (SEPN) 0.6 $12M 611k 18.81
Cullinan Oncology (CGEM) 0.5 $8.2M 1.4M 5.93
Surrozen Com New (SRZN) 0.5 $8.2M 633k 12.88
Perceptive Cap Solutions Cor Cl A Ord Shs (PCSC) 0.4 $8.0M 750k 10.60
Artiva Biotherapeutics (ARTV) 0.3 $4.6M 1.6M 2.87
Tenax Therapeutics Com New (TENX) 0.2 $3.3M 438k 7.61
Casi Pharmaceuticals Ord Shs (CASI) 0.1 $1.6M 987k 1.66